相关实验视频

Updated: Jun 7, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

在帕金森病中,基底状腺网络的推拉效应由功能性MRI推断出来

Yuxin Wang¹, Zhiqi Jiang¹, Chunguang Chu^2,3

¹School of Electrical and Information Engineering, Tianjin University, Tianjin, China.

NPJ Parkinson's disease

|November 20, 2024

概括

帕金森病 (PD) 的深度大脑刺激 (DBS) 通过调整神经网络活动来起作用. DBS增强有益的大脑通路并减少有害的,改善运动症状,如刚性和勃拉迪基尼西亚.

科学领域:

神经科学是一个神经科学.
计算生物学计算生物学
医学物理医学物理

背景情况:

帕金森病 (PD) 的运动症状是用深度大脑刺激 (DBS) 治疗的,但其精确的机制尚未完全理解.
了解受DBS影响的神经回路对于优化PD治疗至关重要.

研究的目的:

通过构建一个多尺度大脑模型来阐明帕金森病中亚thalamic DBS 的机制.
调查基底状腺网络中的"推拉"效应及其与PD症状和DBS治疗的关系.

主要方法:

利用了27名帕金森病患者的fMRI数据,这些患者接受了亚thalamic DBS和30名健康对照.
开发了一种多尺度的大脑模型,以适应皮层-基底 - thalamic神经循环中的微观合参数.
与个体大脑连接和临床症状相关的模型参数.

主要成果:

在基底状腺网络中发现了一种"推拉"效应,在基底状腺网络中,特定的GABAergic投射会影响刚性和勃拉迪基尼西亚.
在PD中多巴胺缺乏与改变的合变异有关,将网络"推入"异常状态.
亚thalamic DBS被证明可以通过增强基底的GABAergic投射来缓解刚性,并通过减少皮质投射来改善布拉迪基尼西亚.

结论:

对帕金森病的DBS治疗通过将神经网络"拉向"健康状态来起作用.
这项研究整合了微观和宏观的神经信息,以推进对PD病理生理学和DBS的理解.
这些发现为改善PD运动症状的DBS疗效提供了机制基础.

更多相关视频

High-resolution Functional Magnetic Resonance Imaging Methods for Human Midbrain

High-resolution Functional Magnetic Resonance Imaging Methods for Human Midbrain

Published on: May 10, 2012

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation

Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation

Published on: February 23, 2020

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...